Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Timing of a single dexmedetomidine dose before laryngoscopy and intubation and its effect on stress response.

Official title: Do Increasing Preoperative Timing of Single Dexmedetomidine Dose Have an Effect on Stress Response of Laryngoscopy and Intubation? A Randomized Controlled Trial

Run by Tanta University · NCT07165483 · Data updated 2026-11-12

This trial will test whether giving one dose of dexmedetomidine earlier or closer to surgery can reduce the blood pressure and heart rate changes caused by laryngoscopy and intubation in adults aged 18–65 with ASA I–II.

More Dexmedetomidine trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment45 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, El-Gharbia)
StatusRecruiting
StartedSeptember 11, 2025
Main results expectedMarch 1, 2026
Study endsMarch 1, 2026
Registry record updatedSeptember 12, 2025
Trial IDNCT07165483 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 in good to moderate health (ASA I–II) scheduled for elective procedures and not taking interfering medications are ideal candidates.

Probably not a fit

Patients with severe cardiovascular or respiratory disease, diabetes, hypertension, obesity, pregnancy, breastfeeding, sleep apnea, or those on certain antihypertensive or heart-rate–altering medications are unlikely to be eligible or to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares a single preoperative dose of dexmedetomidine given at different time points with a saline control to see how timing affects the stress response to laryngoscopy and intubation. Adult patients (18–65 years) with ASA physical status I–II undergoing elective procedures will be assigned to receive dexmedetomidine at one of two preoperative timing windows or saline before induction. Investigators will monitor hemodynamic measures such as heart rate and blood pressure around laryngoscopy and intubation to compare responses between groups. Patients with major cardiovascular or respiratory disease, diabetes, hypertension, obesity, pregnancy, breastfeeding, sleep apnea, use of certain antihypertensive or heart-rate–affecting drugs, or those undergoing emergency procedures are excluded.

Why it matters

Potential benefit: If successful, adjusting the timing of a single dexmedetomidine dose could help reduce the immediate blood pressure and heart rate spikes during laryngoscopy and intubation, improving hemodynamic stability around anesthesia.

How similar studies have gone: Previous studies have shown that dexmedetomidine can blunt the hemodynamic and stress responses to laryngoscopy and intubation, and this study focuses specifically on optimizing the timing of a single dose.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age from 18 to 65 years.
* Both sexes.
* American Society of Anesthesiology (ASA) physical status I-II.

Exclusion Criteria:

* Severe cardiovascular problems.
* Respiratory disorders.
* Diabetes.
* Hypertension.
* Obesity.
* Allergic reaction to study drugs.
* Patients on antihypertensive medication (α-methyldopa, clonidine, or other α2-adrenergic agonists)
* Medications that affect heart rate (HR) or blood pressure (BP).
* Pregnant.
* Currently breast-feeding women.
* History of sleep apnea.
* Those for emergency procedures.

Where it's running

  • Tanta University
    Tanta, El-Gharbia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.